| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.4M | +16.3% |
| SG&A Expense | $7.5M | +25.1% |
| Operating Income | -$22.9M | -19.0% |
| Net Income | -$22.3M | -16.6% |
| EPS (Basic) | -$1.43 | +5.3% |
| EPS (Diluted) | -$1.43 | +5.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.1M | -4.3% |
| Current Assets | $19.2M | -6.0% |
| Total Assets | $19.2M | -6.0% |
| Current Liabilities | $7.0M | +12.9% |
| Total Liabilities | $7.0M | +12.9% |
| Stockholders' Equity | $12.2M | -14.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | -17.7% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $15.1M | -45.7% |